Hye-Ryoun Kim

748 citations
25 papers · 597 indexed · h-index 12
Topics
Lung Cancer Treatments and Mutations (4 papers)Cancer Diagnosis and Treatment (3 papers)Pancreatic and Hepatic Oncology Research (2 papers)

In The Last Decade

Hye-Ryoun Kim

25 papers receiving 581 citations

Peers

Hye-Ryoun Kim
Comparison fields: 5 of 84
  • Pulmonary and Respiratory Medicine 261
  • Oncology 214
  • Molecular Biology 205
  • Cancer Research 159
  • Epidemiology 115
Replace Yehan Zhu with:
Yehan Zhu China
Sandra P. Gibson United States
Jinlu Tong China
Jun-Sang Kim South Korea
Chi Hong Kim South Korea
Alexander P. de Porto Netherlands
Yoshimasa Shiraishi Japan
Jingjing Cong China
Byonggu An Japan
Masaru Morita Japan
Hye-Ryoun Kim relative to Yehan Zhu China Yehan Zhu's profile →
Citations per field
00.5×7.2×
Yehan Zhu · 1×
Citations per year

Countries citing papers authored by Hye-Ryoun Kim

Since Specialization
Citations

This map shows the geographic impact of Hye-Ryoun Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye-Ryoun Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye-Ryoun Kim more than expected).

Fields of papers citing papers by Hye-Ryoun Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye-Ryoun Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye-Ryoun Kim. The network helps show where Hye-Ryoun Kim may publish in the future.

Co-authorship network of co-authors of Hye-Ryoun Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hye-Ryoun Kim. A scholar is included among the top collaborators of Hye-Ryoun Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye-Ryoun Kim. Hye-Ryoun Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 24
3 7
4 11
5 11
6 16
7 32
8 22
9 9
10 150
11 1
12 10
13 63
14 1
15 6
16 1
17 18
18 71
19 1
20 3

About Hye-Ryoun Kim

Hye-Ryoun Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Internal Medicine, having authored 25 papers that have together received 597 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer Diagnosis and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Cancer Research (159 citations), Pulmonary and Respiratory Medicine (261 citations) and Oncology (214 citations). Hye-Ryoun Kim has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Cheol Hyeon Kim, Jae Cheol Lee, Jae‐Joon Yim, Young-Soo Shim, Yun Jung Choi, Jong Seok Lee, Jin Kyung Rho, Jin-Haeng Chung, Ho Il Yoon and Xianhua Xu. Their work appears in journals such as Oncotarget, Lung Cancer and Journal of Experimental & Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026